June Industries Ltd (531960)
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, June Industries' revenue was ₹0.2 Cr, and net profit ₹0.1 Cr (against a loss a year earlier); the operating margin was 72.4%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹0.2 | — | +0.0% |
| Operating profit | ₹0.1 | from loss | from loss |
| Net profit | ₹0.1 | from loss | from loss |
| EPS (₹) | 0.03 | from loss | from loss |
| Operating margin | 72.4% | — | — |
📢 Recent Corporate Announcements
June Industries (formerly Kashyap Tele-Medicines) reported a net profit of Rs 14.46 Lakhs for the quarter ended June 30, 2026, a significant turnaround from a loss of Rs 2.98 Lakhs in the same period last year. Revenue from operations reached Rs 20.00 Lakhs, compared to zero revenue in the year-ago quarter. This quarterly revenue alone matches the company's total revenue for the entire previous financial year (FY26). Total expenses were sharply reduced to Rs 5.70 Lakhs from Rs 49.31 Lakhs in the preceding March 2026 quarter, aiding the return to profitability.
- Revenue from operations grew to Rs 20.00 Lakhs from Rs 0.00 Lakhs in the year-ago quarter.
- Net profit stood at Rs 14.46 Lakhs vs a loss of Rs 2.98 Lakhs in June 2025.
- Total expenses decreased by 88% sequentially to Rs 5.70 Lakhs from Rs 49.31 Lakhs in March 2026.
- Earnings Per Share (EPS) turned positive at Rs 0.030 compared to negative Rs 0.006 YoY.
- The company transitioned its focus to trading pharmaceutical hygiene and cleanroom products.
June Industries reported a revenue of Rs 20.00 Lakhs for Q1 FY27, which effectively matches its entire revenue for the full year FY26 (Rs 19.70 Lakhs). The company achieved a net profit of Rs 14.46 Lakhs, a significant turnaround from a loss of Rs 2.98 Lakhs in the year-ago period and a loss of Rs 27.98 Lakhs in the preceding quarter. This profitability was aided by a sharp 90% QoQ reduction in 'Other Expenses' to Rs 4.78 Lakhs. The company is currently focused on a single segment: trading of pharmaceutical hygiene and cleanroom products.
- Revenue from operations reached Rs 20.00 Lakhs in Q1 FY27 compared to zero revenue in Q1 FY26
- Net profit of Rs 14.46 Lakhs recorded against a net loss of Rs 27.98 Lakhs in Q4 FY26
- Total expenses dropped significantly to Rs 5.70 Lakhs from Rs 49.31 Lakhs in the previous quarter
- Q1 FY27 revenue (Rs 20 Lakhs) represents approximately 101.5% of the total FY26 annual revenue
- Earnings Per Share (EPS) turned positive at 0.030 for the quarter
June Industries Ltd (formerly Kashyap Tele-Medicines) successfully passed all resolutions at its 32nd AGM held on August 10, 2026. Shareholders approved the FY26 audited financial statements and the re-appointment of Mrs. Heena Kalpesh Sheth as Whole-Time Director. Approximately 66.05% of the total share capital participated in the voting, with near-unanimous approval (99.99%). The company continues to operate with minimal revenue, reporting just Rs 0.2 Cr in FY26 with significant negative margins.
- 66.05% of total shares (31,519,726 votes) were polled for the resolutions.
- 99.9998% of votes were cast in favor of adopting the FY26 Audited Financial Statements.
- Total of 8,153 shareholders were on record as of the August 03, 2026 cut-off date.
- Mrs. Heena Kalpesh Sheth re-appointed as Whole-Time Director with 31,519,721 votes in favor.
June In d u s t r i e s L i m i t e d (f o r m e r l y K a s h y a p T e l e - M e d i c i n e s) h e l d i t s 3 2 n d A G M o n A u g u s t 1 0, 2 0 2 6. T h e m e e t i n g f o c u s e d o n t h e a d o p t i o n o f F Y 2 6 a u d i t e d f i n a n c i a l s t a t e m e n t s, w h i c h r e f l e c t a n e t l o s s o f ₹ 0. 4 6 c r o r e o n r e v e n u e o f ₹ 0. 2 c r o r e. S h a r e h o l d e r s a l s o v o t e d o n t h e r e - a p p o i n t m e n t o f M r s. H e e n a K a l p e s h S h e t h a s W h o l e - T i m e D i r e c t o r. T h e c o m p a n y r e m a i n s a m i c r o - c a p w i t h a m a r k e t c a p i t a l i z a t i o n o f ₹ 2 7 c r o r e a n d s i g n i f i c a n t o p e r a t i n g l o s s e s.
- 3 2 n d A n n u a l G e n e r a l M e e t i n g c o n c l u d e d o n A u g u s t 1 0, 2 0 2 6, a t 1 1: 5 1 a. m. I S T.
- A d o p t i o n o f F Y 2 6 f i n a n c i a l s w i t h a r e p o r t e d r e v e n u e o f ₹ 0. 2 c r o r e a n d n e t l o s s o f ₹ 0. 4 6 c r o r e.
- R e - a p p o i n t m e n t o f M r s. H e e n a K a l p e s h S h e t h (D I N: 0 7 6 2 7 6 8 1) a s W h o l e - T i m e D i r e c t o r.
- R e m o t e e - v o t i n g p e r i o d w a s a c t i v e f r o m A u g u s t 7 t o A u g u s t 9, 2 0 2 6.
- T h e A u d i t R e p o r t f o r F Y 2 6 c o n t a i n e d n o q u a l i f i c a t i o n s o r a d v e r s e r e m a r k s.
June Industries Ltd has scheduled a board meeting for August 12, 2026, to approve unaudited financial results for the quarter ended June 30, 2026. The company is a micro-cap with a market capitalization of Rs 27 Cr and has historically struggled with scale, reporting a total revenue of just Rs 0.2 Cr in FY26. Recent performance shows persistent losses, with a net loss of Rs 0.28 Cr in the March 2026 quarter. Investors should note the extremely high Price-to-Book ratio of 148.7 despite the lack of significant revenue.
- Board meeting scheduled for August 12, 2026, to approve Q1 results.
- Company reported a net loss of Rs 0.28 Cr in the preceding quarter (March 2026).
- Total revenue for the full year FY26 was only Rs 0.2 Cr.
- Promoter holding has remained stagnant at 61.93% over the last four quarters.
- Operating profit margin remains deeply negative at -240% for the trailing twelve months.
June Industries (formerly Kashyap Tele-Medicines) has released its FY 2025-26 Annual Report, scheduling its 32nd AGM for August 10, 2026. The company is transitioning its business focus toward pharmaceutical trading, though FY26 performance was weighed down by BSE penalties and higher employee costs. Financial ratios show a negative Net Profit Ratio of -2.34% and a negative ROE of -2.58%, although the Current Ratio improved significantly to 1.40 from 0.22. The company remains debt-free as of March 31, 2026.
- 32nd Annual General Meeting (AGM) to be held on August 10, 2026, via Video Conferencing
- Current Ratio improved to 1.40 in FY26 from 0.22 in FY25
- Net Profit Ratio declined to -2.34% from 0.00% due to BSE penalties and employee expenses
- Return on Equity (ROE) fell to -2.58% from 0.00% year-on-year
- Complete management overhaul noted with new MD and CFO appointed in mid-2025
June Industries Ltd (formerly Kashyap Tele-Medicines) has scheduled its 32nd Annual General Meeting for August 10, 2026. The company is undergoing a strategic transition into pharmaceutical trading, moving away from its previous business model. Financial results for FY26 show a negative Return on Equity of -2.58% and a negative Net Profit Ratio of -2.34%, primarily due to BSE penalties and increased employee expenses. Despite losses, the current ratio improved significantly to 1.40 from 0.22 in the previous year.
- 32nd Annual General Meeting scheduled for August 10, 2026, via Video Conferencing
- Return on Equity (ROE) declined to -2.58% in FY26 from 0.00% in FY25
- Current Ratio improved to 1.40 as of March 31, 2026, compared to 0.22 in the previous year
- Net Profit Ratio reported at -2.34% for FY26, impacted by regulatory penalties
- Management confirmed a business transition into pharmaceutical trading in the annual report
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
